PepT1 uptake, cells and mice
In human intestinal and T-cell lines, KPV was taken into cells through the PepT1 transporter and, at nanomolar concentrations, reduced NF-kB and MAP kinase signalling and the release of inflammatory messengers. Given by mouth in drinking water, it reduced the occurrence of colitis in two chemically induced mouse models, shown by lower inflammatory cytokine expression. The authors proposed KPV as a candidate for inflammatory bowel disease.
- Study type
- Animal
- Population
- Human cell lines (intestinal epithelial and T cells) and mice with chemically induced colitis
- Source
- 1 Dalmasso et al., 2008
Limitation: Cell lines and mice only.
Limitations in full
Cell lines and mice only. The abstract gives no effect sizes or group sizes. Mouse colitis models do not reproduce human inflammatory bowel disease.